About
The Bloomberg of Healthcare, built UK-first
MedTwenty combines a healthcare business publication with a structured intelligence database. It launches with UK coverage and widens as verified records accumulate across the United States, Canada and beyond.
Model wide, reveal narrow
The database is designed for the full healthcare economy from day one, but each product is revealed only when the underlying records earn the claim. We would rather publish less than overstate coverage.
A person signs off every fact
Material facts — deal values, funding rounds, approvals, contract awards — are reviewed against their source and approved by an editor before publication. Automation drafts; humans decide.
Journalism open, intelligence paid
The newsroom stays readable. Membership pays for the structured records, deal terms, research and tooling that professionals use for work.
Say what is known
Pages show what the records support, and say so when something is undisclosed, rumoured or unverified. Indices carry published methodology and are editorial indicators, not benchmarks.
What we publish
Daily news and analysis across NHS policy, pharma and biotech, medtech, diagnostics, digital health, providers, payers, life sciences real estate and healthcare finance. Alongside it: company, investor, executive, technology and market pages, the deal flow tracker, the MedTwenty Indices and the research centre.
Company details, staffing and contact information on this preview are placeholders pending the real details.